• OPEN AN ACCOUNT
Indian Indices
Nifty
24,870.10 -213.65
(-0.85%)
Sensex
81,306.85 -693.86
( -0.85%)
Bank Nifty
55,149.40 -606.05
( -1.09%)
Nifty IT
35,440.85 -283.05
( -0.79%)
Global Indices
Nasdaq
45,658.64 852.13
(1.90%)
Dow Jones
6,488.44 97.27
(1.52%)
Hang Seng
42,587.47 -22.70
(-0.05%)
Nikkei 225
9,321.40 12.20
(0.13%)
Forex
USD-INR
87.05 -0.06
(-0.07%)
EUR-INR
101.38 -0.20
(-0.20%)
GBP-INR
117.29 -0.32
(-0.27%)
JPY-INR
0.59 0.00
(0.13%)

EQUITY - MARKET SCREENER

Dr Lal Pathlabs Ltd
Industry :  Healthcare
BSE Code
ISIN Demat
Book Value()
539524
INE600L01024
254.778098
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
LALPATHLAB
54.54
28269.21
EPS(TTM)
Face Value()
Div & Yield %
61.87
10
0.71
 

Board of HFCL approves fund raising up Rs 700 cr via equity issuance
Jul 25,2025
The Board of HFCL at its meeting held on 25 July 2025 has approved fund raising up to Rs 700 crore in one or more tranches and/or one or more issuances simultaneously or otherwise, by way of an issue of fully paid-up equity shares, any other equity based instruments or securities.

The objective of the fund raising is to effectively leverage emerging growth opportunities in the defence and telecommunications sectors, including strategic investments, and to further strengthen the Company's capital base and financial position. The proceeds from the proposed fund raising will, inter alia, be strategically deployed to support various initiatives central to the Company's growth agenda, including expansion through organic and inorganic means, acquisitions in related space, new business opportunities, and other strategic initiatives, repayment of debt, working capital, general corporate purposes.